Analyst Activity – Cantor Fitzgerald Reiterates Hold on Novavax (NASDAQ:NVAX)

ME Staff
-
0

Analyst Ratings For Novavax (NASDAQ:NVAX)

Today, Cantor Fitzgerald reiterated its Hold rating on Novavax (NASDAQ:NVAX) with a price target of $2.00.

There are 7 hold ratings, 2 buy ratings on the stock.

The current consensus rating on Novavax (NASDAQ:NVAX) is Hold (Score: 2.22) with a consensus target price of $5.71 per share, a potential 278.06% upside.

Some recent analyst ratings include

  • 7/21/2017-Cantor Fitzgerald Reiterated Rating of Hold.
  • 3/1/2017-Ladenburg Thalmann Financial Services Reiterated Rating of Neutral.
  • 2/28/2017-Chardan Capital Reiterated Rating of Hold.
  • 1/18/2017-FBR & Co Reiterated Rating of Outperform.
  • 11/11/2016-Wedbush Reiterated Rating of Neutral.
  • 11/10/2016-J P Morgan Chase & Co Reiterated Rating of Hold.

Recent Insider Trading Activity For Novavax (NASDAQ:NVAX)
Novavax (NASDAQ:NVAX) has insider ownership of 4.00% and institutional ownership of 49.98%.

  • On 5/12/2017 Michael A Mcmanus Jr, Director, bought 20,000 with an average share price of $0.97 per share and the total transaction amounting to $19,400.00. View SEC Filing
  • On 5/11/2017 Barclay A Phillips, CFO, bought 25,000 with an average share price of $0.84 per share and the total transaction amounting to $21,000.00. View SEC Filing
  • On 5/11/2017 Michael A Mcmanus Jr, Director, bought 10,000 with an average share price of $0.84 per share and the total transaction amounting to $8,400.00. View SEC Filing
  • On 5/11/2017 Stanley C Erck, Insider, bought 50,000 with an average share price of $0.84 per share and the total transaction amounting to $42,000.00. View SEC Filing
  • On 1/31/2017 Barclay A. Phillips, CFO, bought 1,633 with an average share price of $1.12 per share and the total transaction amounting to $1,828.96. View SEC Filing
  • On 1/31/2017 John A. Herrmann III, SVP, bought 4,960 with an average share price of $1.12 per share and the total transaction amounting to $5,555.20. View SEC Filing
  • On 12/7/2016 Gregory M Glenn, Insider, bought 1,000 with an average share price of $1.45 per share and the total transaction amounting to $1,450.00. View SEC Filing

Recent Trading Activity for Novavax (NASDAQ:NVAX)
Shares of Novavax closed the previous trading session at 1.51 up +0.09 6.34% with 11,355,338 shares trading hands.